* Oceanpine Capital submitted a preliminary non-binding proposal to acquire all outstanding shares of LakeShore Biopharma (NASDAQ:LSB [https://seekingalpha.com/symbol/LSB]) not already owned.
* The proposed all-cash offer is $0.86/share, representing a 10.3% premium to the August 15, 2025, closing price and 11.4% premium to the 15-day average.
* The transaction would be funded by rollover equity and available cash, with no financing condition.
* LakeShore’s board will evaluate the proposal.
* LSB shares up 1.3% premarket on Monday.
* Source: Press release [https://seekingalpha.com/pr/20203520-lakeshore-biopharma-announces-receipt-of-a-preliminary-non-binding-proposal-to-acquire-the]
MORE ON LAKESHORE BIOPHARMA
* Financial information for LakeShore Biopharma [https://seekingalpha.com/symbol/LSB/income-statement]
LakeShore Biopharma receives $0.86/share buyout proposal from Oceanpine Capital
Published 2 months ago
Aug 18, 2025 at 1:04 PM
Positive
Auto